Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Aberrant Helix Pomatia Agglutinin Binding Glycan Expression Changes With the Phenotype of Follicular Thyroid Tumours

NCT05052359 is registered in ClinicalTrials.gov with National University Health System, Singapore as lead sponsor.

NCT NCT05052359
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05052359 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Aberrant Helix Pomatia Agglutinin Binding Glycan Expression Changes With the Phenotype of Follicular Thyroid Tumours
Lead sponsor
National University Health System, Singapore
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
September 1, 2021
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

follicular thyroid cancer